Office of Public Health Emergency Preparedness; Statement of Organization, Functions, and Delegations of Authority, 38403-38405 [06-6004]
Download as PDF
<![CDATA[
jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 71, No. 129 / Thursday, July 6, 2006 / Notices
• Economic justification/value
proposition
• Fee is too high
• Oppose fee
• Overall increase to Government
Cost
• Increase in TSP fees and
administrative burden
• Fee must not apply to existing
tenders
• TSP must be given time to adjust
rates
• Fee must apply universally to all
TSPs
• TSPs shouldn’t collect and pay
transaction fees
The following responses take into
consideration the comments on the
potential impact of the proposed rule on
both GSA and the transportation
industry.
GSA must fund its programs to
remain viable and cover the cost of the
services provided by the freight
program. GSA’s Federal Supply Service
(FSS) has assessed an industrial funding
fee for essentially all of its programs
since Congress authorized GSA to
charge fees for its services in 1987. The
proposed 4% transaction fee aligns the
Global Supply transportation services
with GSA’s funding mechanism for its
other programs.
TSPs will realize additional savings
through reduction in administrative
requirements to process invoices. TSPs
that provide transportation services for
GSA, Global Supply will benefit from
TMSS electronic billing, electronic rate
submission, automated prepayment
audit, faster payments, online
transaction tracking, automated reports,
and complete audit history trails.
After careful deliberations GSA
decided to delay assessment of the 4%
transaction fee until the TMSS prepayment audit and payment modules
are complete. TSPs will be required to
remit the 4% fee for paid invoices
directly to GSA quarterly instead of
deducting the 4% fee from each invoice
via TMSS prior to payment. The Final
Rule outlining the collection method
and implementation plan will be
published in the Federal Register once
the TMSS modules are complete. The
proposed changes will be highlighted in
a Request for Offers that will be issued
for a special rate filing window that will
be opened prior to implementation.
GSA will monitor the shipment volume
to determine if the 4% fee needs future
adjustments. GSA wants to ensure that
the appropriate percentage is being
applied.
VerDate Aug<31>2005
17:01 Jul 05, 2006
Jkt 208001
Dated: June 29, 2006.
Susan T. May,
Acting Director, Travel and Transportation
Management Division (FBL), GSA.
[FR Doc. E6–10579 Filed 7–5–06; 8:45 am]
BILLING CODE 6820–89–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Office of Public Health Emergency
Preparedness; Statement of
Organization, Functions, and
Delegations of Authority
Part A, Office of the Secretary,
Statement of Organization, Functions,
and Delegations of Authority of the
Department of Health and Human
Services (HHS) is being amended at
Chapter AN, Office of Public Health
Emergency Preparedness, as last
amended at 70 FR 5183–5184, dated
February 1, 2005. This organizational
change is primarily to realign the
functions of OPHEP to more clearly
delineate responsibilities for the various
activities associated with advanced
research and development and
acquisition of medical countermeasures
and emergency preparedness and
response. The changes are as follows.
I. Under Part A, Chapter AN, ‘‘Office
of Public Health Emergency
Preparedness (AN),’’ delete in its
entirety and replace with the following:
Section AN.00 Mission: On behalf of
the Secretary, the Office of Public
Health Emergency Preparedness
(OPHEP) leads the Federal public health
and medical response to acts of
terrorism or nature, and other public
health and medical emergencies.
OPHEP is a component of the Public
Health Service (PHS) and is responsible
for ensuring a One-Deparmtent
approach to developing public health
and medical preparedness and response
capabilities and leading and
coordinating the relevant activities of
the HHS Operating Division (OPDIV).
The principal areas of program
emphasis are (1) enhancement of State
and local public health and medical
preparedness—primarily health
departments and hospitals; (2)
development and use of National and
Departmental policies and plans relating
to the response to public health and
medical threats and emergencies (e.g.,
Emergency Support Function (ESF) 8 of
the National Response Plan (NRP),
Homeland Security Presidential
Directives (HSPD) 5 and 10, HHS’s
Concept of Operations Plans (CONOPS)
for Public Health and Medical
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
38403
Emergencies and for the Incident
Response Coordination Team (IRCT));
(3) coordination with relevant entities
inside and outside HHS such as State,
local and Tribal public health and
medical officials, the private sector, the
Departments of Homeland Security
(DHS), Defense (DOD), Veterans Affairs
(VA), Justice (DOJ), the Homeland
Security Council (HSC) and National
Security Council (NSC), other ESF 8
partner organizations and others within
the National security community; (4)
rapid public health and medical support
to Federal, State, local and Tribal
governments who may be responding to
incidents of national significance or
public health and medical emergencies;
(5) coordination, support of, and
participation in research, development
and procurement activities related to
public health emergency medical
countermeasures destined for the
Strategic National Stockpile, including
under Project BioShield; (6) leadership
in international programs, initiatives,
and policies that deal with public health
and medical emergency preparedness
and response related to naturally
occurring threats such as infectious
deceases and deliberate threats from
biologic, chemical, nuclear and
radiation sources and (7) leadership and
oversight on medical, science, and
public health policies, issues, and
programs.
Section 10.AN Organization: OPHEP
is headed by the Assistant Secretary for
Public Health Emergency Preparedness
(ASPHEP), who reports directly to the
Secretary, and includes the following
components:
1. Immediate Office of the ASPHEP
(ANA)
2. Office of the Public Health
Emergency Medical Countermeasures
(ANB)
3. Office of Preparedness and
Emergency Operations (ANC)
4. Office of Medicine, Science and
Public Health (ANF)
5. Office of Policy and Strategic
Planning (ANE)
Section 20.AN Functions:
1. Immediate Office of the ASPHEP
(ANA). The Immediate Office of the
ASPHEP (IO/ASPHEP) provides
executive and administrative direction
to all OHEP components. The ASPHEP
is the principal advisor to the Secretary
on matters relating to public health and
medical emergencies, whether resulting
from acts of nature, accidents, or
terrorism. The ASPHEP coordinates
interagency interfaces between HHS, the
Homeland Security Council, the
National Security Council, other Federal
Departments and Agencies, State, local
and Tribal public health and medical
E:\FR\FM\06JYN1.SGM
06JYN1
jlentini on PROD1PC65 with NOTICES
38404
Federal Register / Vol. 71, No. 129 / Thursday, July 6, 2006 / Notices
entities and the private sector. The
ASPHEP directs and coordinates the
Department’s activities relating to
protecting the U.S. population from acts
of terrorism and other public health and
medical threats and emergencies. The
ASPHEP provides leadership in the
coordination of activities for public
health and medical emergency
preparedness and represents the
Department in working closely with
DHS, DOD, VA, and other Federal
Departments and Agencies.
2. Office of Public Health Emergency
Medical Countermeasures (ANB). The
Office of Public Health Emergency
Medical Countermeasures (OPHEMC) is
headed by a Director and is responsible
for coordination of the Public Health
Medical Countermeasures Enterprise
(PHMCE). The PHMCE is a coordinated
interagency effort to: (1) Define and
prioritize requirements for public health
medical emergency countermeasures,
(2) coordinate research, early and late
stage product development and
procurement activities addressing the
requirements and (3) set deployment
and use strategies for medical
countermeasures held in the Strategic
National Stockpile.
OPHEMC undertakes public health
modeling of population exposures to
assist in determining requirements and
assessing deployment and utilization
strategies, supports late-stage medical
countermeasure research and
development to address prioritized
requirements for addressing the health
effects of naturally-occurring infectious
diseases and deliberately released
biologic, and chemical and radiation
threats that could cause a public health
emergency, facilitates collaboration
among the Department of Health and
Human Services agencies, relevant
industries, academia, and others with
respect to advanced product research
and development, facilitates contacts
between interested persons and
companies interested in requirements
set by the Food and Drug
Administration regarding such
products, and procures targeted medical
countermeasures destined for the
Strategic National Stockpile, including
vaccines, antivirals, and diagnostics for
pandemic preparedness authorized
under the Project BioShield Act of 2004
(Pub. L. 108–276). OPHEMC is
responsible for coordinating,
supporting, and providing leadership
and expert advice with respect to a
public health medical countermeasure
late stage advanced development and
procurement. OPHEMC supports the
ASPHEP by working with all scientific
agencies of the Department, including
the National Institutes of Health (NIH),
VerDate Aug<31>2005
17:01 Jul 05, 2006
Jkt 208001
the Centers for Disease Control and
Prevention (CDC), the Food and Drug
Administration (FDA), as well as other
Governmental, private ,and nonprofit
scientific entities.
3. Office of Preparedness and
Emergency Operations (ANC). The
Office of Preparedness and Emergency
Operations (OPEO) is headed by a
Director and is responsible for
developing operational plans, analytical
products, and developing and
participating in training and exercises to
ensure the preparedness of the Office,
the Department, the Government and
the public to respond to domestic and
international public health and medical
threats and emergencies. OPEO is also
responsible for ensuring that OPHEP has
the systems, logistical support and
procedures necessary to coordinate the
Department’s operational response to
acts of terrorism and other public health
and medical threats and emergencies.
OPEO leads the HHS and interagency
planning and response activities
required to fulfill HHS responsibilities
under ESF #8 of the NRP and HSPD #10.
OPEO manages the Secretary’s
Operations Center (SOC); trains and
manages the Incident Response
Coordination Team (IRCT); plans,
implements, and evaluates
Departmental and interagency response
exercises and the HHS Continuity of
Operations (COOP) and Continuity of
Government (COG) programs. OPEO
maintains a regional planning and
response coordination capability. OPEO
has operational responsibility for HHS
functions related to the National
Disaster Medical Systems (NDMS) and
is also the primary operational liaison to
emergency response entities within
HHS (e.g., FDA, HRSA, SAMHSA, CDC),
within the interagency community (e.g.,
HDS, VA, DoD), and the public. OPEO
manages the continued planning for
capabilities to meet public health and
medical response missions, including
development of Federal Medical
Stations (FMS) and other mobile
medical units. OPEO works to integrate
mass casualty preparedness activities,
through its surge capacity efforts, across
local, State and Federal levels consistent
with the National Incident Management
System (NIMS) and the National
Response Plan Catastrophic Incident
Annex. In collaboration with DHS,
OPEO coordinates preparedness grant
activities across the Department in
compliance with HSPD 8 and the
National Preparedness Goal. OPEO is
the primary OPHEP liaison with the
Health Resources and Services
Administration (HRSA) regarding its
programs for hospital bioterrorism
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
preparedness, volunteer health
professionals and terrorism-related
preparedness and response education
and training for health care
professionals. OPEO coordinates with
CDC on public health preparedness
issues and consults with the HHS
scientific community on the inclusion
of newly acquired countermeasures into
response plans.
4. Office of Medicine, Science and
Public Health (ANF). The Office of
Medicine, Science and Public Health
(OMSPH) is headed by a Director and is
responsible for providing expert
medical, scientific, and public health
advice on domestic and international
medical preparedness policies,
programs, initiatives, and activities of
OPHEP. OMSPH serves as the OPHEP
liaison to health and science
professional organizations for domestic
and international issues. OMSPH carries
out special scientific and public health
related projects directly and works with
others to establish activities, programs,
policies, and standards to protect the
public from acts of terrorism, naturally
occurring infectious disease threats, and
other natural or man-made public health
threats. OMSPH coordinates OPHEP’s
overall influenza pandemic effort and
works closely with HHS components
(e.g., National Vaccine Program Office,
Office of Global Health Affairs, CDC,
NIH, and FDA), and other agencies and
offices such as the Department of State,
the U.S. Department of Agriculture
(USDA) and the World Health
Organization (WHO) to ensure that
programs and plans for dealing with
avian influenza and pandemic influenza
are as effective as possible. OMSPH
oversees the development of medical
policies related to providing access to
medical products, including those
needed on an emergency basis as
medical countermeasures to counteract
terrorism or naturally occurring
biological, chemical or radiological/
nuclear threats. These policies and their
implementation include use of
investigational and emergency use
authorities. OMSPH serves as the focal
point in HHS for biosafety, biosecurity
and dual use technology issues and is
the liaison to the National Science
Advisory Board on Biosecurity and to
the State Department on the Biological
and Chemical Weapons Convention. In
addition to domestic issues and
programs, OMSPH is the OPHEP focal
point for all international activities
related to public heath emergency
preparedness. OMSPH supports the
Early Warning Infectious Disease
Surveillance (EWIDS) program at the
national borders with Mexico and
E:\FR\FM\06JYN1.SGM
06JYN1
jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 71, No. 129 / Thursday, July 6, 2006 / Notices
Canada and works with other nations
and multilateral organizations (e.g.,
WHO) in combating public health
threats, emergencies, and bioterrorism
by establishing bilateral and multilateral
international arrangements to develop
early warning surveillance and response
capability for infectious disease
outbreaks, including those involving
potential bioterrorism agents. OMSPH
provides leadership in the activities of
the regional and multilateral groups
including the Global Health Security
Action Group (GHSAG) and the Security
and Prosperity Partnership (SPP) and
the implementation of the WHO
International Health Regulations (IHR),
in coordination with the Office of
Global Health Affairs.
5. Office of Policy and Strategic
Planning (ANE). The Office of Policy
and Strategic Planning (OPSP) is headed
by a Director and is responsible for
policy formulation, analysis,
coordination, and evaluation for
preparedness, response, and strategic
planning. In coordination with other
OPHEP and Departmental offices, OPSP
analyzes proposed policies, Presidential
directives and regulations. OPSP also
develops short and long-term policy and
strategic objectives for OPHEP, and
leads in the development and
implementation of an integrated OPHEP
approach to policy, strategy, and longterm, planning processes. On behalf of
the ASPHEP, OPSP serves as the focal
point for HSC/NSC policy coordination
activities and represent the ASPHEP, as
appropriate, in interagency meetings.
The office undertakes studies of
preparedness and response issues,
identifying gaps in policy, and initiating
policy planning and formulation to fill
these gaps. OPSP takers the lead on
special projects, initiatives, and policy
analysis and evaluation as tasked by the
ASPHEP.
II. Continuation of Policy: Except as
inconsistent with this reorganization, all
statements of policy and interpretations
with respect to the Office of Public
Health Emergency Preparedness
heretofore issued and in effect prior to
the date of this reorganization are
continued in full force and effect.
III. Delegations of Authority: All
delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
IV. Funds, Personnel and Equipment:
Transfer of organizations and functions
affected by this reorganization shall be
accompanied in each instance by direct
VerDate Aug<31>2005
17:01 Jul 05, 2006
Jkt 208001
and support funds, positions, personnel,
records, equipment and other resources.
Dated: June 27, 2006.
Joe Ellis,
Assistant Secretary for Administration and
Management.
[FR Doc. 06–6004 Filed 7–5–06; 8:45 am]
38405
Dated: June 29, 2006.
Kathy Skipper,
Acting Director, Management Analysis and
Services Office , Centers for Disease Control
and Prevention.
[FR Doc. 06–6035 Filed 7–5–06; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4150–37–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): HIV III—OPTOut Testing in Emergency Department
Settings, Program Announcement (PA)
PS06–003
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): HIV III—OPTOut Testing in Emergency Department
Settings, PA PS06–003.
Time and Date: 12 p.m.–1 p.m., July
12, 2006 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the review, discussion, and
evaluation of applications received in
response to ‘‘HIV III—OPT-Out Testing
in Emergency Department Settings,’’ PA
PS06–003. Due to programmatic
matters, this Federal Register Notice is
being published on less than 15
calendar days notice to the public (41
CFR 102–3.150(b)).
Contact Person for More Information:
Jim Newhall, Ph.D., Scientific Review
Administrator, Office of Public Health
Research, CDC, 1600 Clifton Road NE,
Mailstop D72, Atlanta, GA 30333,
Telephone 404.639.4641.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, Tools and
Technology to Measure Menopausal
Symptomotology.
Date: July 24, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary,
and Alternative Medicine, NIH, 6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Laurie Friedman Donze,
PhD, Scientific Review Administrator, Office
of Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301–402–1030,
donzel@mail.nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, Tools and
Technology to Measure Patient Adherence in
CAM Research.
Date: July 25, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Alternative Medicine, NIH, 6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Laurie Friedman Donze,
PhD, Scientific Review Administrator, Office
of Scientific Review, National Center for
Complementary and Alternative Medicine,
E:\FR\FM\06JYN1.SGM
06JYN1
]]>Agencies
[Federal Register Volume 71, Number 129 (Thursday, July 6, 2006)]
[Notices]
[Pages 38403-38405]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6004]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Office of Public Health Emergency Preparedness; Statement of
Organization, Functions, and Delegations of Authority
Part A, Office of the Secretary, Statement of Organization,
Functions, and Delegations of Authority of the Department of Health and
Human Services (HHS) is being amended at Chapter AN, Office of Public
Health Emergency Preparedness, as last amended at 70 FR 5183-5184,
dated February 1, 2005. This organizational change is primarily to
realign the functions of OPHEP to more clearly delineate
responsibilities for the various activities associated with advanced
research and development and acquisition of medical countermeasures and
emergency preparedness and response. The changes are as follows.
I. Under Part A, Chapter AN, ``Office of Public Health Emergency
Preparedness (AN),'' delete in its entirety and replace with the
following:
Section AN.00 Mission: On behalf of the Secretary, the Office of
Public Health Emergency Preparedness (OPHEP) leads the Federal public
health and medical response to acts of terrorism or nature, and other
public health and medical emergencies. OPHEP is a component of the
Public Health Service (PHS) and is responsible for ensuring a One-
Deparmtent approach to developing public health and medical
preparedness and response capabilities and leading and coordinating the
relevant activities of the HHS Operating Division (OPDIV). The
principal areas of program emphasis are (1) enhancement of State and
local public health and medical preparedness--primarily health
departments and hospitals; (2) development and use of National and
Departmental policies and plans relating to the response to public
health and medical threats and emergencies (e.g., Emergency Support
Function (ESF) 8 of the National Response Plan (NRP), Homeland Security
Presidential Directives (HSPD) 5 and 10, HHS's Concept of Operations
Plans (CONOPS) for Public Health and Medical Emergencies and for the
Incident Response Coordination Team (IRCT)); (3) coordination with
relevant entities inside and outside HHS such as State, local and
Tribal public health and medical officials, the private sector, the
Departments of Homeland Security (DHS), Defense (DOD), Veterans Affairs
(VA), Justice (DOJ), the Homeland Security Council (HSC) and National
Security Council (NSC), other ESF 8 partner organizations and others
within the National security community; (4) rapid public health and
medical support to Federal, State, local and Tribal governments who may
be responding to incidents of national significance or public health
and medical emergencies; (5) coordination, support of, and
participation in research, development and procurement activities
related to public health emergency medical countermeasures destined for
the Strategic National Stockpile, including under Project BioShield;
(6) leadership in international programs, initiatives, and policies
that deal with public health and medical emergency preparedness and
response related to naturally occurring threats such as infectious
deceases and deliberate threats from biologic, chemical, nuclear and
radiation sources and (7) leadership and oversight on medical, science,
and public health policies, issues, and programs.
Section 10.AN Organization: OPHEP is headed by the Assistant
Secretary for Public Health Emergency Preparedness (ASPHEP), who
reports directly to the Secretary, and includes the following
components:
1. Immediate Office of the ASPHEP (ANA)
2. Office of the Public Health Emergency Medical Countermeasures
(ANB)
3. Office of Preparedness and Emergency Operations (ANC)
4. Office of Medicine, Science and Public Health (ANF)
5. Office of Policy and Strategic Planning (ANE)
Section 20.AN Functions:
1. Immediate Office of the ASPHEP (ANA). The Immediate Office of
the ASPHEP (IO/ASPHEP) provides executive and administrative direction
to all OHEP components. The ASPHEP is the principal advisor to the
Secretary on matters relating to public health and medical emergencies,
whether resulting from acts of nature, accidents, or terrorism. The
ASPHEP coordinates interagency interfaces between HHS, the Homeland
Security Council, the National Security Council, other Federal
Departments and Agencies, State, local and Tribal public health and
medical
[[Page 38404]]
entities and the private sector. The ASPHEP directs and coordinates the
Department's activities relating to protecting the U.S. population from
acts of terrorism and other public health and medical threats and
emergencies. The ASPHEP provides leadership in the coordination of
activities for public health and medical emergency preparedness and
represents the Department in working closely with DHS, DOD, VA, and
other Federal Departments and Agencies.
2. Office of Public Health Emergency Medical Countermeasures (ANB).
The Office of Public Health Emergency Medical Countermeasures (OPHEMC)
is headed by a Director and is responsible for coordination of the
Public Health Medical Countermeasures Enterprise (PHMCE). The PHMCE is
a coordinated interagency effort to: (1) Define and prioritize
requirements for public health medical emergency countermeasures, (2)
coordinate research, early and late stage product development and
procurement activities addressing the requirements and (3) set
deployment and use strategies for medical countermeasures held in the
Strategic National Stockpile.
OPHEMC undertakes public health modeling of population exposures to
assist in determining requirements and assessing deployment and
utilization strategies, supports late-stage medical countermeasure
research and development to address prioritized requirements for
addressing the health effects of naturally-occurring infectious
diseases and deliberately released biologic, and chemical and radiation
threats that could cause a public health emergency, facilitates
collaboration among the Department of Health and Human Services
agencies, relevant industries, academia, and others with respect to
advanced product research and development, facilitates contacts between
interested persons and companies interested in requirements set by the
Food and Drug Administration regarding such products, and procures
targeted medical countermeasures destined for the Strategic National
Stockpile, including vaccines, antivirals, and diagnostics for pandemic
preparedness authorized under the Project BioShield Act of 2004 (Pub.
L. 108-276). OPHEMC is responsible for coordinating, supporting, and
providing leadership and expert advice with respect to a public health
medical countermeasure late stage advanced development and procurement.
OPHEMC supports the ASPHEP by working with all scientific agencies of
the Department, including the National Institutes of Health (NIH), the
Centers for Disease Control and Prevention (CDC), the Food and Drug
Administration (FDA), as well as other Governmental, private ,and
nonprofit scientific entities.
3. Office of Preparedness and Emergency Operations (ANC). The
Office of Preparedness and Emergency Operations (OPEO) is headed by a
Director and is responsible for developing operational plans,
analytical products, and developing and participating in training and
exercises to ensure the preparedness of the Office, the Department, the
Government and the public to respond to domestic and international
public health and medical threats and emergencies. OPEO is also
responsible for ensuring that OPHEP has the systems, logistical support
and procedures necessary to coordinate the Department's operational
response to acts of terrorism and other public health and medical
threats and emergencies. OPEO leads the HHS and interagency planning
and response activities required to fulfill HHS responsibilities under
ESF 8 of the NRP and HSPD 10. OPEO manages the
Secretary's Operations Center (SOC); trains and manages the Incident
Response Coordination Team (IRCT); plans, implements, and evaluates
Departmental and interagency response exercises and the HHS Continuity
of Operations (COOP) and Continuity of Government (COG) programs. OPEO
maintains a regional planning and response coordination capability.
OPEO has operational responsibility for HHS functions related to the
National Disaster Medical Systems (NDMS) and is also the primary
operational liaison to emergency response entities within HHS (e.g.,
FDA, HRSA, SAMHSA, CDC), within the interagency community (e.g., HDS,
VA, DoD), and the public. OPEO manages the continued planning for
capabilities to meet public health and medical response missions,
including development of Federal Medical Stations (FMS) and other
mobile medical units. OPEO works to integrate mass casualty
preparedness activities, through its surge capacity efforts, across
local, State and Federal levels consistent with the National Incident
Management System (NIMS) and the National Response Plan Catastrophic
Incident Annex. In collaboration with DHS, OPEO coordinates
preparedness grant activities across the Department in compliance with
HSPD 8 and the National Preparedness Goal. OPEO is the primary OPHEP
liaison with the Health Resources and Services Administration (HRSA)
regarding its programs for hospital bioterrorism preparedness,
volunteer health professionals and terrorism-related preparedness and
response education and training for health care professionals. OPEO
coordinates with CDC on public health preparedness issues and consults
with the HHS scientific community on the inclusion of newly acquired
countermeasures into response plans.
4. Office of Medicine, Science and Public Health (ANF). The Office
of Medicine, Science and Public Health (OMSPH) is headed by a Director
and is responsible for providing expert medical, scientific, and public
health advice on domestic and international medical preparedness
policies, programs, initiatives, and activities of OPHEP. OMSPH serves
as the OPHEP liaison to health and science professional organizations
for domestic and international issues. OMSPH carries out special
scientific and public health related projects directly and works with
others to establish activities, programs, policies, and standards to
protect the public from acts of terrorism, naturally occurring
infectious disease threats, and other natural or man-made public health
threats. OMSPH coordinates OPHEP's overall influenza pandemic effort
and works closely with HHS components (e.g., National Vaccine Program
Office, Office of Global Health Affairs, CDC, NIH, and FDA), and other
agencies and offices such as the Department of State, the U.S.
Department of Agriculture (USDA) and the World Health Organization
(WHO) to ensure that programs and plans for dealing with avian
influenza and pandemic influenza are as effective as possible. OMSPH
oversees the development of medical policies related to providing
access to medical products, including those needed on an emergency
basis as medical countermeasures to counteract terrorism or naturally
occurring biological, chemical or radiological/nuclear threats. These
policies and their implementation include use of investigational and
emergency use authorities. OMSPH serves as the focal point in HHS for
biosafety, biosecurity and dual use technology issues and is the
liaison to the National Science Advisory Board on Biosecurity and to
the State Department on the Biological and Chemical Weapons Convention.
In addition to domestic issues and programs, OMSPH is the OPHEP focal
point for all international activities related to public heath
emergency preparedness. OMSPH supports the Early Warning Infectious
Disease Surveillance (EWIDS) program at the national borders with
Mexico and
[[Page 38405]]
Canada and works with other nations and multilateral organizations
(e.g., WHO) in combating public health threats, emergencies, and
bioterrorism by establishing bilateral and multilateral international
arrangements to develop early warning surveillance and response
capability for infectious disease outbreaks, including those involving
potential bioterrorism agents. OMSPH provides leadership in the
activities of the regional and multilateral groups including the Global
Health Security Action Group (GHSAG) and the Security and Prosperity
Partnership (SPP) and the implementation of the WHO International
Health Regulations (IHR), in coordination with the Office of Global
Health Affairs.
5. Office of Policy and Strategic Planning (ANE). The Office of
Policy and Strategic Planning (OPSP) is headed by a Director and is
responsible for policy formulation, analysis, coordination, and
evaluation for preparedness, response, and strategic planning. In
coordination with other OPHEP and Departmental offices, OPSP analyzes
proposed policies, Presidential directives and regulations. OPSP also
develops short and long-term policy and strategic objectives for OPHEP,
and leads in the development and implementation of an integrated OPHEP
approach to policy, strategy, and long-term, planning processes. On
behalf of the ASPHEP, OPSP serves as the focal point for HSC/NSC policy
coordination activities and represent the ASPHEP, as appropriate, in
interagency meetings. The office undertakes studies of preparedness and
response issues, identifying gaps in policy, and initiating policy
planning and formulation to fill these gaps. OPSP takers the lead on
special projects, initiatives, and policy analysis and evaluation as
tasked by the ASPHEP.
II. Continuation of Policy: Except as inconsistent with this
reorganization, all statements of policy and interpretations with
respect to the Office of Public Health Emergency Preparedness
heretofore issued and in effect prior to the date of this
reorganization are continued in full force and effect.
III. Delegations of Authority: All delegations and redelegations of
authority made to officials and employees of affected organizational
components will continue in them or their successors pending further
redelegation, provided they are consistent with this reorganization.
IV. Funds, Personnel and Equipment: Transfer of organizations and
functions affected by this reorganization shall be accompanied in each
instance by direct and support funds, positions, personnel, records,
equipment and other resources.
Dated: June 27, 2006.
Joe Ellis,
Assistant Secretary for Administration and Management.
[FR Doc. 06-6004 Filed 7-5-06; 8:45 am]
BILLING CODE 4150-37-M
